Adirondack Trust Company’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.1K | Sell |
173
-47
| -21% | -$7.05K | 0.01% | 320 |
|
|
2026
Q1 | $33.6K | Hold |
220
| – | – | 0.01% | 293 |
|
|
2025
Q4 | $30.3K | Hold |
220
| – | – | 0.01% | 295 |
|
|
2025
Q3 | $28.2K | Sell |
220
-8
| -4% | -$976 | 0.01% | 310 |
|
|
2025
Q2 | $27.6K | Hold |
228
| – | – | 0.01% | 290 |
|
|
2025
Q1 | $25.4K | Hold |
228
| – | – | 0.01% | 291 |
|
|
2024
Q4 | $22.2K | Sell |
228
-61
| -21% | -$6.5K | 0.01% | 299 |
|
|
2024
Q3 | $33.2K | Hold |
289
| – | – | 0.01% | 272 |
|
|
2024
Q2 | $30.8K | Hold |
289
| – | – | 0.01% | 272 |
|
|
2024
Q1 | $28K | Hold |
289
| – | – | 0.01% | 277 |
|
|
2023
Q4 | $29.2K | Sell |
289
-100
| -26% | -$9.65K | 0.01% | 276 |
|
|
2023
Q3 | $39.6K | Buy |
389
+159
| +69% | +$16.1K | 0.02% | 239 |
|
|
2023
Q2 | $24.1K | Sell |
230
-326
| -59% | -$32.6K | 0.01% | 254 |
|
|
2023
Q1 | $51.2K | Hold |
556
| – | – | 0.03% | 202 |
|
|
2022
Q4 | $50.4K | Hold |
556
| – | – | 0.03% | 200 |
|
|
2022
Q3 | $42K | Buy |
556
+426
| +328% | +$35.3K | 0.02% | 207 |
|
|
2022
Q2 | $11K | Hold |
130
| – | – | 0.01% | 301 |
|
|
2022
Q1 | $11K | Hold |
130
| – | – | 0.01% | 312 |
|
|
2021
Q4 | $11K | Hold |
130
| – | – | 0.01% | 299 |
|
|
2021
Q3 | $11K | Hold |
130
| – | – | 0.01% | 307 |
|
|
2021
Q2 | $12K | Hold |
130
| – | – | 0.01% | 292 |
|
|
2021
Q1 | $11K | Hold |
130
| – | – | 0.01% | 292 |
|
|
2020
Q4 | $12K | Hold |
130
| – | – | 0.01% | 269 |
|
|
2020
Q3 | $11K | Hold |
130
| – | – | 0.01% | 242 |
|
|
2020
Q2 | $11K | Hold |
130
| – | – | 0.01% | 241 |
|
|
2020
Q1 | $11K | Hold |
130
| – | – | 0.01% | 225 |
|
|
2019
Q4 | $12K | Hold |
130
| – | – | 0.01% | 240 |
|
|
2019
Q3 | $11K | Hold |
130
| – | – | 0.01% | 246 |
|
|
2019
Q2 | $12K | Sell |
130
-15
| -10% | -$1.27K | 0.01% | 250 |
|
|
2019
Q1 | $11K | Hold |
145
| – | – | 0.01% | 243 |
|
|
2018
Q4 | $11K | Hold |
145
| – | – | 0.01% | 236 |
|
|
2018
Q3 | $11K | Hold |
145
| – | – | 0.01% | 250 |
|
|
2018
Q2 | $10K | Hold |
145
| – | – | 0.01% | 251 |
|
|
2018
Q1 | $10K | Hold |
145
| – | – | 0.01% | 249 |
|
|
2017
Q4 | $11K | Hold |
145
| – | – | 0.01% | 236 |
|
|
2017
Q3 | $11K | Buy |
+145
| New | +$11K | 0.01% | 231 |
|
Other funds holding NVS
Adirondack Trust Company's NVS Position: Q2 2026 in Review
Adirondack Trust Company reduced its Novartis (NVS) stake by 21% in Q2 2026, selling an estimated $7.05K and leaving 173 shares worth $27.1K. The position accounts for 0.01% of the portfolio, ranked #320.
Adirondack Trust Company first reported a position in NVS in Q3 2017 and has held it in 36 quarters since. The position peaked at $51.2K in Q1 2023. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Adirondack Trust Company held 173 shares of Novartis worth $27.1K as of Q2 2026.
- Adirondack Trust Company sold 47 Novartis shares in Q2 2026, an estimated $7.05K.
- Novartis made up 0.01% of Adirondack Trust Company's portfolio in Q2 2026, its #320 holding.
- Adirondack Trust Company first reported a position in Novartis in Q3 2017 and has held it in 36 quarters since.
- Adirondack Trust Company's Novartis position peaked at $51.2K in Q1 2023.
- 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.